PW

Pallavi Wanve

Active Director Director DIN 07825169
DIN 07825169 First appointment May 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since May 2017
Shareholding value •••• Premium profile

About Pallavi Wanve

Data last updated:

Pallavi Wanve is a Director at Niramaya Hospitals Private Limited (since 2023), Director at Radiant Diagnostic Center Private Limited (since 2020) and Designated Partner at Jamkhed Pride Diagnostic Center Llp (since 2020), and holds 1 more current directorship. The companies operate in Healthcare and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹41.73 Cr; the largest is Niramaya Hospitals Private Limited at ₹40.78 Cr (FY 2024). Earlier, Pallavi Wanve was a Director at Chandrafull Cattle Feeds Private Limited (2017–2021) and Director at Polestar Diagnostic Center Private Limited (from 2017).

DIN 07825169
Primary Designation Director
Industry Healthcare
First Appointment 18 May 2017
Oldest Company Age 26 yrs
Largest company Niramaya Hospitals Private Limited · ₹40.78 Cr (FY 2024)
Combined revenue ₹41.73 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Niramaya Hospitals Private Limited U55101PN2000PTC014383
Director07 Jan 20232000₹40.78 Cr (FY 2024)Active
Director01 Sep 20202020₹95 Lakh (FY 2025)Active
Designated Partner12 Nov 20202020Active
Designated Partner30 Sep 20202017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 May 20172017Strike Off
Director11 Jul 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jamkhed Pride Diagnostic Center Llp
Dighi Diagnostic Llp
Radiant Diagnostic Center Private Limited
Polestar Diagnostic Center Private Limited
Premium access

Shareholding and investment profile for Pallavi Wanve

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi Wanve

Pallavi Wanve currently holds 4 directorships: Niramaya Hospitals Private Limited (Director, since 07 Jan 2023, revenue ₹40.78 Cr (FY 2024)); Radiant Diagnostic Center Private Limited (Director, since 01 Sep 2020, revenue ₹95 Lakh (FY 2025)); Jamkhed Pride Diagnostic Center Llp (Designated Partner, since 12 Nov 2020); Dighi Diagnostic Llp (Designated Partner, since 30 Sep 2020).

Pallavi Wanve was first appointed on 18 May 2017 as Director at Chandrafull Cattle Feeds Private Limited. The most recent appointment on record is 07 Jan 2023 at Niramaya Hospitals Private Limited.

The 2 current companies of Pallavi Wanve that report revenue have a combined latest revenue of ₹41.73 Cr: Niramaya Hospitals Private Limited ₹40.78 Cr (FY 2024); Radiant Diagnostic Center Private Limited ₹95 Lakh (FY 2025).

Pallavi Wanve held 2 earlier board appointments: Chandrafull Cattle Feeds Private Limited (Director, 18 May 2017 to 31 Mar 2021); Polestar Diagnostic Center Private Limited (Director, from 11 Jul 2017).

The current boards of Pallavi Wanve's companies include Kisanrao Bibhishan Mundhe (Niramaya Hospitals Private Limited), Manisha Uttamrao Kale (Niramaya Hospitals Private Limited), Pratibha Machindra Hargude (Niramaya Hospitals Private Limited), Richa Kashliwal (Niramaya Hospitals Private Limited), Sagar Kadam (Niramaya Hospitals Private Limited), Maruti Dhakane (Radiant Diagnostic Center Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available